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Abstract 
Background: CASP1 variants result in reduced enzymatic activity of procaspase-1 and impaired IL-1β 
release. Despite this, a subset of carriers develops the clinical picture of systemic autoinflammation. 
These on the first view contradictory observations can at least partially be explained by increased NF-
κB activation through prolonged interaction of variant procaspase-1 with receptor interacting protein 
kinase (RIP)2. However, little is known about the exact molecular events resulting in pro-
inflammatory signaling. 
Aim: We aimed to characterize the subcellular localization of variant procaspase-1, their influence on 
IL-1β release, cell proliferation, phagocytosis and pro-inflammatory cell death (pyroptosis). 
Methods: An in vitro model for the study of CASP1 variants was established through shRNA-directed 
knock-down of endogenous procaspase-1 followed by viral transduction of human monocytes (THP-1) 
with expression plasmids either encoding wild-type or enzymatically inactive procaspase-1 fusion-
reporter proteins. We analyzed subcellular (pro)caspase-1 distribution, inflammasome assembly, and 
the induction of pyroptosis using fluorescence and confocal microscopy, life-time imaging and 
Western blot. Proliferation and phagocytosis were assessed using the IncuCyte® live-cell analysis 
system in combination with pH sensitive probes (e.g. pHrodo E. coli microparticle). Macrophage cell 
shape changes were investigated by real-time deformability cytometry (RT-DC). 
Results: THP-1-derived macrophages carrying CASP1 variants were characterized by mutation-
specific molecular alterations. The p.L265S variant resulted in disturbed nuclear localization of 
(pro)caspase-1 and reduced formation of cytosolic macromolecular complexes (also called specks or 
pyroptosomes) after inflammasome stimulation. The p.R240Q variant, as well as an artificial active 
center mutation of procaspase-1 (p.C285A) promoted speck formation, resulting in increased speck 
size, which may lead to the amplification of inflammatory signals in response to release of 
pyroptosomes to the extracellular space. The p.C285A variant additionally mediated impaired 
inflammatory cell death. Proliferation and phagocytosis of monocytes/macrophages was not 
influenced by CASP1 variants investigated, but macrophage deformability was increased after 
inflammasome stimulation, potentially influencing cell shape changes and migration properties. 
Conclusions: Despite reduced enzymatic activity, CASP1 variants result in pro-inflammatory 
phenotypes. Besides an increased association/interaction of variant procaspase-1 with RIP2, and 
therefore enhanced NF-κB activation, we here provide in vitro evidence that abnormal pyroptosome 
formation (p.C285A, p.240Q, p.L265S), impaired nuclear protein localization (p.L265S), reduced pro-
inflammatory cell death (p.C285A) and changes in macrophage deformability could contribute to 
disease pathophysiology of CASP1-AID patients.  
 
Introduction 
Naturally occurring variants of the caspase-1 (CASP1) gene were recently identified in patients with 
recurrent fevers and other signs of systemic inflammation [1]. The term CASP1-associated 
autoinflammatory disease (CASP1-AID) has been suggested to characterize this disorder. In most 
cases, symptoms start in early childhood and include febrile episodes (> 38.5°C) lasting 3 days to 3 
weeks, systemic inflammation with C-reactive protein elevation >50 mg/l, and additional complaints, 
including arthralgia, myalgia and/or exanthema. Some patients exhibit abdominal pain, diarrhea, and 
lymphadenopathy. 
The CASP1 gene locates to chromosome 11q22.3, comprises 10 exons (NM_033292; NCBI RefSeq 
[2]) and encodes for procaspase-1. Most of the identified point mutations are located in exon 6, which 
encodes for the p20 subunit of procaspase-1. Thus, mutations closely localize to the active center of 
caspase-1 and interfere with hetero-tetramer formation through destabilization of water-mediated 
hydrogen bonds and hydrophobic interactions at the dimer-dimer interface [1].  
Caspase-1 is activated in response to the recognition of pathogen and/or danger associated molecular 
patterns (PAMPs or DAMPs) through intracellular sensors including NOD-like receptors (NLR). This 
results in a conformational change allowing for associations with the apoptosis associated speck-like 
protein containing a CARD (ASC), leading to caspase-1 activation and enzymatic cleavage of pro-
interleukin (IL)-1β and pro-IL-18 into their active forms. Furthermore, direct proximity of procaspase-
1 molecules results in activation and auto-processing of caspase-1 into the N-terminal caspase 
recruitment domain (CARD), a central p20 and a C-terminal p10 subunit. The hetero-tetrameric 
assembly of two p10 and two p20 subunits results in active caspase-1.  
The analysis of caspase-1 variants in an in vitro cell model (resembling the cellular phenotype of 
CASP1-AID) revealed variant specific decreased or abrogated enzyme activity and subsequently 
impaired IL-1β secretion [1]. Whole blood samples of patients confirmed reduced IL-1β secretion, 
however elevated pro-inflammatory TNF-α levels [1]. The paradox of an inflammatory phenotype in 
the absence of caspase-1 enzyme activity led to the hypothesis of an upregulation of alternative pro-
inflammatory pathways in individuals with CASP1 variants. Recently, we supported this by 
demonstrating enhanced NF-кB activation through variant procaspase-1, which is dependent on 
receptor interacting protein kinase (RIP)2. In the context of CASP1-AID, CARD:CARD interactions 
between RIP2 and procaspase-1 variants are stabilized which results in increased NF-кB activation 
[3].  
Caspase-1 is not only a key regulator of the innate immune response activating pro-inflammatory 
cytokines IL-1β and IL-18. It also promotes pyroptosis, an inflammatory form of programmed cell 
death, by cleaving the pore-forming effector protein gasdermin D (GSDMD) [4]. This leads to plasma 
membrane pore formation, cell swelling and burst by osmotic lysis and subsequently the release of 
highly pro-inflammatory cellular components [5, 6]. In this pyroptosis contrasts apoptosis, in which 
cellular compartments are condensed and subject to phagocytic uptake of membrane covered apoptotic 
bodies preventing inflammation. 
Pyroptosis is further characterized by the formation of a macromolecular ASC aggregate (ASC speck) 
preceding cell swelling and cell death. This ASC speck formation has first been described in 1999 in 
promyelocytic leukemia HL-60 cells, where it was linked to apoptosis [7]. Eight years later, in 2007, 
Fernandes-Alnemri and colleagues extended this notion by observing cytosolic ASC speck formation 
in the perinuclear region of immune cells (monocytes) after lipopolysaccharide (LPS) stimulation, 
subsequently inducing pyroptosis [8]. Therefore, they introduced the term “pyroptosome” for this 
spherical cytosolic ASC-aggregate/-speck. Recently, the “pyroptosome” polymerization mechanism 
has been revealed up to a nearly molecular level [9, 10]. After recognition of PAMPs or DAMPs by 
pyrin domain (PYD) containing receptors like NLRP3 or AIM2, these receptors oligomerize and 
attract the adapter protein ASC via heterotypic PYD:PYD interaction. The PYD of ASC forms helical 
filamentous structures (via homotypic PYD:PYD interaction), exposing the CARD of ASC in the 
periphery. Those CARDs further recruit procaspase-1 via heterotypic CARD:CARD interaction [9, 
10] forming a macromolecular speck. Although it is still subject of ongoing discussions, the formation 
of pyroptosomes and inflammasomes are considered as the same phenomenon [11]. ASC specks serve 
as activation platforms, recruiting and activating caspase-1. 
Of note, speck formation is required for IL-1β processing but not for induction of cell death [12]. 
Recently, it has been described that pyroptosomes/specks released after cell lysis remained active in 
the extracellular compartment and kept processing procaspase-1 and pro-IL-1β [13, 14]. In addition, 
specks were engulfed by macrophages, hence amplifying the inflammatory response within these cells. 
The in vivo relevance of pyroptosome uptake has been highlighted by detecting increased levels of 
pyroptosomes in the sera of patients with cryopyrin associated periodic syndrome (CAPS), an 
autoinflammatory disease with gain-of-function mutations within the NLRP3 gene [13]. 
Additionally, ASC has been suggested to compete with the CARD of RIP2 for binding of procaspase-
1 CARD, thereby leading to the down regulation of RIP2-mediated NF-кB activation [15]. 
Furthermore, ASC is reported to modulate actin polymerization, thus influencing migration of 
lymphocytes [16]. Finally, ASC activates the transcription of a variety of regulators of apoptosis, 
proliferation and differentiation, including the initiator caspase-8 and -9, the effector caspase-3, the 
AP-1 signaling pathways (inducing the pro-inflammatory cytokine IL-8), mitogen-activated protein 
kinase (MAPK) and NF-кB [17-21].  
This study was to investigate the molecular pathophysiology of loss-of-function mutations in the 
CASP1 gene of patients with CASP1-AID. We provide in vitro evidence of the importance of 
pyroptosome formation and macrophage deformability in the disease pathophysiology of CASP1-AID 
patients.   
 
Experimental procedures  
Plasmids 
The plasmid encoding human procaspase-1 was a kind gift from Prof. J. Tschopp (University of 
Lausanne, Lausanne, Switzerland). The procaspase-1 p.R240Q, p.L265S and p.C285A variants were 
generated by site directed mutagenesis using the QuickChangeII XL Site-Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA) following standard protocols. cDNA fragments of wild type procaspase-1 
and the variants were cloned into the lentiviral transfer vector p6NST51 or p6NST53 (kindly provided 
by Prof. Dirk Lindemann, Institute of Virology, University Hospital Carl Gustav Carus, Technische 
Universität Dresden, Germany) and fused to either mCherry or pEGFP at their N-terminus. The two 
plasmids p6NST51 and p6NST53 only differed in their resistance for eukaryotic selection and are a 
variant of p6NST50 [22, 23]. mCherry and EGFP plasmids were purchased from Clontech (Mountain 
View, CA). All constructs underwent quality control by restriction enzyme digestion and Sanger 
sequencing. 
 
Antibodies and reagents 
The following antibodies were used: anti-IL-1β (H-153), anti–procaspase-1 A-19 (sc-622), anti-
caspase-1 p20 C-15 (sc-22163) (all Santa Cruz Biotechnology, Santa Cruz, CA); anti-ASC (AL177; 
AdipoGen, Epalinges, Schweiz), anti-mCherry (1C51; Abcam, Cambridge, UK), anti-GAPDH 
(H86045M; Meridian Life Science, Saco, USA), anti-β-Actin (A2228; Sigma-Aldrich, St. Louis, 
USA), horseradish peroxidase (HRP)-linked anti-rabbit (NA9340; GE Healthcare, Freiburg, 
Germany), HRP-linked anti-mouse (P0260; DakoCytomation, Glostrup, Denmark), HRP-linked anti-
goat (AP186P; Merck Millipore, Billerica, USA), Alexa Fluor 488-linked anti-rabbit (A-11008), 
Alexa Fluor 488-linked anti-mouse (A-11001) (both Life Technologies, Darmstadt, Germany). 
Nigericin and ultra-pure LPS from E. coli O111:B4 were obtained from InvivoGen (Toulouse, 
France), Ponceau from (Santa Cruz Biotechnology, Santa Cruz, CA). Nuclei in life cell imaging 
experiments were stained with NucBlue® Live ReadyProbes® Reagent (ThermoFisher Scientific, 
Schwerte, Germany). 
 
Cell lines and cell culture procedures 
The human monocytic cell line THP-1 was originally isolated from a patient with acute monocytic 
leukemia and is widely used to study immunological processes, e.g. caspase-1 and inflammasome 
activation [8, 24, 25]. THP-1 cells express inflammasome components such as NLRP1, NLRP3, 
NLRC4, apoptosis speck like protein containing a CARD (ASC) and caspase-1. After inflammasome 
stimulation they are able to process and secrete IL-1β. THP-1 monocytic cells usually grow in 
suspension but can be differentiated to macrophages by adding phorbol-12-myristate-3-acetate (PMA), 
then adhering to cell surfaces. This stimulation upregulates toll-like receptor 4 (TLR4), which is 
necessary for LPS sensing. TLR4 activation by LPS is followed by the upregulation of inflammasome-
associated components such as Pro-IL-1β, ASC, NLRP3. 
We established an in vitro model of a virally transduced human monocytic cell line (THP-1, ATCC 
TIB-202, LGC Standards GmbH, Wesel, Germany) with shRNA knock-down of endogenous 
procaspase-1 (a-PCasp1, against the 3’-UTR) reconstituted with either wildtype or variant procaspase-
1 fusion-reporter proteins. Briefly, the expression of endogenous procaspase-1 was knocked down 
using the shRNA expression vector plKO.1 (Addgene, Cambridge, MA). The following target 
sequences were used: CASP1-3’-untranslated region, AAGAGATCCTTCTGTAAAGGT and control, 
AAGACCTCTTGTTAAGAGAGT. Lentiviral vector particles were produced in HEK293T cells 
(ATCC, LGC Standards GmbH, Wesel, Germany) transfected with lentiviral transfer plasmids and 
plasmids psPAX2 and pVSVg. THP-1 cells were transduced with plkO.1 lentiviral stocks and selected 
with puromycin. Protein knockdown was analyzed by Western blotting. This cell line was then 
reconstituted with wildtype or variant caspase-1 by transduction of lentiviral vector particles with a 
multiplicity of infection (MOI) of 0.1 (p6NST51.mCherry.CASP1) or 0.2 (p6NST53.EGFP.CASP1) 
and selected with zeocin or G418 respectively. THP-1 cells were cultivated in 5% CO2 at 37°C in 
RPMI medium 1640 supplemented with 2 mM L-glutamine, 10% fetal calf serum (FCS) and 100 U/ml 
penicillin and 100 µg/ml streptomycin (all Life Technologies).  
HEK 293T cell lines were grown at 37°C in humidified atmosphere of air with 5% CO2 in DMEM 
supplemented with 2 mM L-glutamine, 10% FCS and penicillin/ streptomycin. 
 
Image processing and quantification of pyroptosome formation 
Pyroptosome formation in THP-1 cells was analyzed by immunofluorescence analysis of 
mCherry/EGFP caspase-1 specks. THP-1 cells were cultured in 0.7 cm2 chambers (8-well Lab-Tek 
chambered coverglass system; ThermoFisher Scientific), stimulated as described, stained with 
NucBlue® Live ReadyProbes® Reagent (ThermoFisher Scientific, Schwerte, Germany) and 
subsequently imaged using a Zeiss Axiovert 200M microscope (Carl Zeiss Microscopy GmbH, 
Germany) and a Zeiss Plan-Apochromat 10x/0.45NA objective and reflectors for Hoechst staining 
(EX 340-380 nm, EM 435-485 nm), GFP (EX 465-495 nm, EM 500-540nm) and cherry (EX 530-560 
nm, EM 590-650 nm). A CCD Coolsnap HQ camera (Photometrics, USA) and Visiview/MetaMorph 
(Visitron Systems GmbH, Puchheim, Germany) software was used for data acquisition. Live cell 
imaging was conducted in RPMI (ThermoFisher Scientific) at 37°C and 5% CO2 at the light 
microscopy facility BIOTEC/CRTD. 
Image processing was carried out with ImageJ/Fiji software [26](http://imagej.nih.gov/ij/; 
http://fiji.sc/Fiji). Specks/pyroptosomes were counted manually in the mCherry- or GFP-channel, total 
cell numbers were determined by quantification of nuclei in the Hoechst channel. Speck intensity was 
measured as the maximum intensity of each speck. For analysis of the speck diameter, the full-width at 
half-maximum intensity was applied. 
 
Protein expression analysis  
Caspase-1 was measured in serum-free cell supernatants or cell lysates by SDS PAGE, using caspase-
1 polyclonal Ab (sc-514; Santa Cruz, CA), and IL-1β polyclonal Ab (AF-401-NA; R&D Systems, 
Minneapolis, MN). Cells were lysed and processed as reported previously [3, 15]. Cell lysates were 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), subjected to 
Western blotting, and immunochemical detection using the respective antibodies.  
 
Measurement of secreted IL-1β 
Concentrations of mature IL-1β in the supernatant were determined using cytometric bead arrays 
(CBA) from Becton Dickinson (Franklin Lakes, NJ). 
Immunoblotting of precipitated supernatant was performed by adding an equal volume of methanol 
and 0.25 volumes of chloroform followed by centrifugation for 3 min at 20,000 g. The upper phase 
was discarded, the same volume of methanol added and centrifuged for 3 min at 20,000 g. The 
precipitate was dried and taken up in LDS-sample buffer containing reducing agent (Invitrogen), 
denatured for 10 min at 95°C and separated by Bis-Tris denaturing SDS-PAGE. Proteins were blotted 
onto 0.2 mM nitrocellulose membranes, blocked in 3% milk and incubated with indicated primary and 
corresponding secondary antibodies. Chemiluminescent signals were recorded with a CCD-camera 
and respective images contrast-enhanced in a linear fashion. 
 
Assessment of cell death 
Cells were cultured in serum-free RPMI with 1% ITS-G, L-glutamine and penicillin/streptomycin and 
stimulated as indicated. Cells treated with 0.1% TritonX-100 were used as death positive control. 
LDH-release into supernatant was determined with the Cytotoxicity Detection Kit PLUS (Roche 
Applied Science, Mannheim, Germany) following manufacturer’s instructions.   
 
Immunofluorescence staining, Confocal and fluorescence microscopy  
THP-1 cells were incubated on collagen coated culture slides (BioCoat 8-Well Collagen Culture Slide, 
BD 354630) and differentiated with 2.5 ng/ml PMA overnight, primed and stimulated as indicated and 
fixed in 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) for 15 min at room temperature, 
washed and permeabilized in PBS containing 0.04% saponin (Sigma-Aldrich, St. Louis, MO) and 1% 
BSA (Sigma-Aldrich, St. Louis, MO) for 1 h. Next, cells were stained with appropriate primary 
antibodies for 1 h, followed by staining with fluorochrome-labeled secondary antibodies for 45 min. 
Cover slips were mounted on glass slides in 4′,6-Diamidin-2-phenylindol (DAPI) containing 
Vectashield mounting medium from Vector Laboratories (Burlingame, CA). Slides were subjected to 
imaging on an inverted Zeiss LSM 510 confocal microscope (Carl Zeiss, Jena, Germany) with a 40× 
or 63 × 1.4NA objective lens or on an inverted Leica TCS SP5 microscope (Leica Microsystems, 
Wetzlar, Germany) using a Leica HC PL APO 40x/0.7NA. An argon laser was used for excitation of 
Alexa Fluor 488 at wavelengths of 488 nm, whereas a helium-neon laser (543 nm) was used for 
excitation of mCherry, and a Laser Diode (405 nm) for the excitation of Hoechst or DAPI. 
 
Cell viability assay (Alamar Blue) 
Cell viability was assessed using Alamar Blue Cell Viability Assay (DAL1100, Life Technologies, 
Grand Island, USA) by following the manufacturer’s instructions. 2.5 x 105 THP-1 cells were seeded 
in 24-well plates with 500 µl RPMI Medium 1640 supplemented with 2 mM L-glutamine, 10% fetal 
calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin (all Life Technologies) and primed with 2.5 
ng/ml PMA overnight. After 24 h 50 µl Alamar Blue reagent was added to the cell culture medium. 
Fluorescence signals were measured at 570/600 nm (excitation/emission) on the microplate reader 
Infinite M200 (Tecan).  
 
Cell cycle analysis 
For cell cycle analysis 2 x 105 THP-1 cells/ 6-well were synchronized by serum starvation. After four 
days the cell cycle was restarted (RPMI 1640 media with 10 % FCS) and the cells cultured for 
additional four days. Cells were collected, resuspended in PBS and permeabilized by adding drop-wise 
ice-cold ethanol (to a final concentration of 70%), incubated for 1 h at 4°C. Samples were centrifuged 
at 400×g for 5 minutes, resuspended in PBS containing 50 μg/ml propidium iodide (PI) plus 50 μg/ml 
RNase A and incubated for 30 minutes at 37°C protected from light. Thereafter, cells were analyzed of 
PI fluorescence on a LSRII flow cytometer (BD Biosciences).   
 
Cell proliferation assay  
Cell proliferation was assayed using an IncuCyte® ZOOM Live-Cell Analysis System (Essen 
BioScience, Ann Arbor, MI, USA), by collecting real-time data of cell confluence. Cells were seeded 
on 96-well plates (4,000 cells/well) and analyzed over 40 hours. Cell confluence was monitored and 
data were obtained by analyzing the cell confluence increment over time using the IncuCyte S2 
software and expressed as percentage relative to time point 0. Experiments were conducted with three 
replicates for each experimental condition, two to four image fields per well and repeated at least three 
times. 
 
Phagocytosis assay  
Phagocytosis was assayed using an IncuCyte® ZOOM Live-Cell Analysis System (Essen BioScience, 
Ann Arbor, MI, USA). Cells were seeded on 96-well plates (4,000 cells/well), treated with 2.5 ng/ml 
PMA for 24 hours. pHrodo™ Green E. coli BioParticles were added, and the increase of green 
fluorescence was analyzed by scanning the plate and acquiring fluorescent and phase-contrast images 
in real time. Two to three images per well from three technical replicates were taken every 20 min for 
4 hours using a 20x objective lens. Images were analyzed using the IncuCyte Basic Software and 
expressed as percentage of green object confluence increase relative to time point 0.  Green channel 
acquisition time was 400 ms. Cell segmentation was achieved by applying a mask in order to exclude 
cells from background. An area filter was applied to exclude objects below 50 µm2. Green channel 
background noise was subtracted with the Top-Hat method of background non-uniformity correction. 
Fluorescence signal was quantified applying a mask. 
 
Real-time deformability cytometry (RT-DC) 
RT-DC in combination with a custom-made image analysis algorithm allows determination of 
properties of single cells such as cell size, contour and deformation in real-time [27]. In brief, THP-1 
cells with a shRNA knockdown of endogenous procaspase-1 and re-constitution of procaspase-1 
wildtype or variants were differentiated to macrophages with PMA (2.5 ng/ml) over night and primed 
with LPS (2 µg/ml) for 3 h. Cells were centrifuged at 300 xg for 10 min and resuspended in PBS (2 x 
106 cells/300 μl) without magnesium and calcium with 0.5% methylcellulose (36718 Methyl cellulose, 
viscosity 4000 cPs , Alfa Aesar). Cells were stimulated with 5 µM nigericin directly before measuring. 
The cell suspension was flowed through a microfluidic channel constriction of 30 μm width at a flow 
rate of 0.16 μl/s and measured for 45 min every 3 min. Every single cell was illuminated with an LED 
and imaged with a camera. After background subtraction, the contour is determined in real-time and 
cells are computed in real-time. Inertia ratio and volume of the cell were also calculated based on the 
contour, as described in [28]. In brief, the inertia ratio origins from the second moment of area, and is 
the ratio of elongation in flow direction and orthogonal to it. Volume of cells is computed by a 
mathematical rotation of the contour around the axis defined by the centroid of the cell and the flow 
direction [28]. The algorithms to obtain inertia ratio and volume as well as all other analysis tool for 
RT-DC data are available through the open source software ShapeOut 0.8.8. (available at 
https://github.com/ZELLMECHANIK-DRESDEN/ShapeOut). 
 
Statistics 
Statistical analysis was performed using GraphPad Prism and SPSS software. Statistical analysis for 
IL-1β secretion (out of 7 independent experiments) was examined using two-way Anova and multiple 
comparison test adjusted by Bonferroni. The statistical significance for the cumulative numbers of 
specks (out of 4 independent experiments) was determined using two-way Anova and multiple 
comparison test adjusted by Bonferroni. The statistical analysis for speck diameters was performed 
using one-way Anova with Sidiak’s multiple comparison test.  P-values are indicated by *, p < 0.05; 
**, p < 0.01; *** p < 0.001; ****, p < 0.0001, or n.s. = not significant. 
 
Results 
Generation of genetically modified human monocyte cell lines expressing variant procaspase-1 
To investigate whether CASP1 variants p.R240Q, p.L265S and p.C285A [1] influence proliferation, 
phagocytosis, and cell death of human monocytes/macrophages, we generated and established an in 
vitro model of a virally transduced human monocytic cell lines (THP-1). Initially, we induced shRNA-
mediated knock-down of endogenous procaspase-1 (THP-1/a-PCasp1, down to ~20%) and then 
reconstituted caspase-1 expression with plasmids either encoding for wild-type (WT) or variant 
procaspase-1 (p.R240Q, p.L265S and an artificial p.C285A variant with an active center mutation, 
Fig. 1A,B and Suppl. Fig. 1A,B) linked or not linked to fusion-reporter proteins. Transduction 
efficiency was tested by fluorescence-based flow cytometry analysis (data not shown), Western 
blotting (Fig. 1A and Suppl. Fig. 1A,B) and quantitative RT-PCR (Fig. 1C). Despite comparable 
mRNA expression between cell lines generated and despite using different multiplicity of infection 
(MOI), protein expression differed repeatedly between lines, showing higher protein levels for the WT 
fusion reporter protein when compared to all of the procaspase-1 variants. Of note, almost comparable 
protein expression levels were achieved between tagged and untagged cell lines with a MOI of 0.06. 
However, the p.L265S variant showed repeatedly lower expression levels (Fig. 1A). Thus, “untagged” 
cell lines served as controls for further experiments with the fusion-reporter protein transduced THP-
1/a-PCasp1 cells.  
To determine cell proliferation, cell health and viability of all cell lines generated, we used the real-
time quantitative live cell imaging IncuCyte platform (Essen Bioscience) and quantified cell 
confluence over time. As shown in Suppl. Fig. 1C, cell proliferation was not affected by fluorescent 
tags and did not show differences for the analyzed procaspase-1 variants when compared to wildtype 
cells. 
The biological functionality of the new THP-1 monocyte model was further evaluated mimicking 
bacterial infection with LPS priming and stimulation with either nigericin or ATP as an activator of 
the NLRP3 inflammasome. IL-1β secretion, measured by cytometric bead array (CBA) (Fig. 1D) and 
Western blot analysis of cell culture supernatants (Fig. 1E), was used as readout for caspase-1 
activation. In response to LPS and nigericin, cells expressing WT procaspase-1 (GFP-WT) secreted 
significantly more mature IL-1β as compared to GFP control cells or the inactive procaspase-1 variant 
p.C285A, and slightly more than the naturally occurring variants p.L265S, and p.R240Q  (Fig. 1D). 
Consistent with these observations, we were able to detect the mature form of IL-1β by Western 
blotting in the supernatant of cell lines challenged under the same conditions (Fig. 1E).  
 
Procaspase-1 variants influence pyroptosome formation 
A characteristic sign of inflammasome activation within a single cell is the formation of a perinuclear 
ASC speck, which can also be referred to as pyroptosome [5, 8] or even as inflammasome [11], 
containing multimerized sensor (e.g. NLRP3), adaptor (ASC), and effector (caspase-1) proteins. We 
previously demonstrated in murine cells that procaspase-1 and the enzymatically inactive p.C284A 
variant are recruited to the pyroptosome [29]. Therefore, we performed experiments to determine 
whether human monocyte cell lines bearing procaspase-1 variants p.R240Q, p.L265S and p.C285A 
exhibit speck formation in response to inflammasome activation, and if speck formation differs 
between variants. 
Assuming that the monocyte cell model generated sufficiently reproduces physiological macrophage 
functions in vitro and is not affected by fluorescent tags (see Fig. 1 and Suppl. Fig. 1), we conducted 
live cell imaging experiments with THP-1/a-PCasp1 cells reconstituted with either WT or variant 
procaspase-1 fusion-reporter proteins. THP-1 monocytes were differentiated to macrophages overnight 
using 2.5 ng/ml phorbol 12-myristate 13-acetate (PMA). In response to stimulation with LPS alone, 
cells did not show remarkable changes (data not shown). After priming with LPS followed by the 
addition of nigericin GFP-WT and variant procaspase-1 cell lines (GFP-C285A, GFP-L265S, and 
GFP-R240Q) formed one cytosolic macromolecular speck after approximately 45-60 min, which  
remained for more than 5 hours (Fig. 2A,B). Consistent with previous data [29], the p.C285A variant 
formed a bigger and significantly brighter speck when compared to WT cells. Remarkably, 
procaspase-1 p.L265S resulted in significantly decreased speck numbers and reduced signal intensity. 
Speck number and intensity in the p.R240Q variant were comparable to those in WT but showed 
increased speck size. 
Next, we tested whether GFP-WT or GFP-L265S specks had resolved before detection by microscopy 
contributing to the differences observed regarding speck numbers at time point 310 min (Fig. 2A). We 
analyzed speck numbers on images acquired from a time-series (over 6 hours after NLRP3 stimulation 
with nigericin at 10 min intervals). The number of newly formed specks were added to speck number 
on previous slides at each time point, gaining a cumulative speck number (Fig. 2B,C). Differences 
(Fig. 2A) were confirmed with significantly decreased number of specks/pyroptosomes in procaspase-
1 variants p.C285A and p.L265S when compared to WT and p.R240Q at the time points 240, 300 and 
360 min.  
Interestingly, speck sizes did not associate with enzyme activity of procaspase-1 variants. To quantify 
speck sizes, we used the “mean of half maximum intensity” method and analyzed the fluorescence 
microscopy images, which have been acquired for the experiments in Fig. 2A-C and determined a 
mean procaspase-1 speck diameter of 1.21 μm (SD ± 0.336) in GFP-WT cells, 1.44 µm (SD ± 0.496) 
in GFP-C285A cells, 1.12 µm (SD ± 0.361) in GFP-L265S cells and 1.44 µm (SD ± 0.517) in GFP-
R240Q cells. Specks of GFP-C285A and GFP-R240Q cells were significantly larger when compared 
to GFP-WT specks. Specks in GFP-L265S cells were smaller than those in GFP-WT cells which, 
however, did not reach statistical significance (p=0.07) (Fig. 2D). Therefore we performed higher 
resolution imaging using a confocal microscope. As shown in Fig. 2E, specks for the procaspase-1 
p.L265S variant were significantly smaller than WT specks. 
Using life cell fluorescence microscopy imaging, we noticed differences in speck intensities between 
cell lines (Fig. 2A). Measuring speck intensities over time, we observed procaspase-1 specks fading in 
GFP-WT cells almost immediately after their formation (within 20 min) (Fig. 2F). GFP-R240Q 
specks remained slightly brighter and fading occurred slower (within 40 min), and signal intensities 
remained at a higher level when compared to GFP-WT. Specks in GFP-L265S cells only reached a 
signal intensity that was around 2/3 of that in GFP-WT cells, which faded within 20 min (almost to the 
background before pyroptosome formation) (Fig. 2F, -10 min time point). In contrast, GFP-C285A 
specks remained more stable and showed significantly slower fading. Differences were quantified at 
time points 100 min and 200 min (Fig. 2G) demonstrating significantly brighter specks in GFP-
C285A and significantly dimmer specks in GFP-L265S when compared to GFP-WT cells.  
As previously demonstrated [29], within the same cell, WT caspase-1 specks decrease more rapidly in 
fluorescence intensity when compared to ASC stained specks, suggesting caspase-1 auto-processing as 
a possible explanation. Here, we also demonstrate rapid speck fading and decreased speck intensity in 
cells expressing variant procaspase-1 p.L265S, which lacks enzymatic activity [1]. Assuming that 
p.L265S is not capable of auto-processing, we wondered about dynamics and distribution of caspase-1 
subunits. We stained stimulated THP-1/a-PCasp1 cells reconstituted with either mCherry (Ch) or the 
fluorescent fusion proteins Ch-WT or Ch-L265S (all with comparable protein expression, Suppl. Fig. 
1B) with antibodies directed against CARD, the p10 or p20 subunit of caspase-1 (Fig. 3A). Both in 
Ch-WT and Ch-L265S cells, specks co-localized with CARD, p10 and p20. Thus, we concluded that 
mCherry signals represent the localization of procaspase-1 within speck, as has been previously 
demonstrated by our group for the murine p.C284A variant [29]. Furthermore, in Ch-WT and Ch-
L265S cells, procaspase-1 specks co-localize with ASC after NLRP3 stimulation (Fig. 3A). 
Interestingly, in contrast to reduced numbers of caspase-1 specks in Ch-L265S cells when compared to 
Ch-WT monocytes, all cell lines (Ch-WT, Ch-L265S, Ch) generated the same amount of ASC-specks 
(Fig. 3B).   
Furthermore, in both cell lines, Ch-WT and Ch-L265S, nigericin stimulation resulted not only in speck 
formation but also in pyroptosis, shown by an increase in cell volume, the presence of cell membrane 
vesicles, and a decrease in intracellular mCherry fluorescence intensity due to the release of plasma 
membrane vesicles (Suppl. Fig. 1D+E). 
 
Variant procaspase-1 p.L265S results in disturbed subcellular localization  
To study subcellular localization of procaspase-1 in macrophages, we performed life cell confocal 
laser scanning microscopy of PMA-differentiated THP-1 monocytes, showing cytoplasmic and 
nuclear localization of the mCherry signal in WT cells (Fig. 3C,D). Interestingly, Ch-WT cells, in 
which functional caspase-1 can self-process, exhibited predominantly nuclear localization of the 
CARD domain and the p10 subunit, but not of the p20 subunit. Cells with the enzymatically attenuated 
procaspase-1 variant p.L265S (Ch-L265S) almost exclusively exhibited caspase-1 localization in the 
cytoplasm (Fig. 3C,D). 
To exclude the possibility that subcellular distribution of fusion reporter proteins differs from 
endogenous procaspase-1 localization, we performed antibody staining of endogenous procaspase-1 
using native THP-1 and a-PCasp1 cells (Suppl. Fig. 2A). Corresponding to results in Ch-WT cells, we 
observed slightly increased fluorescent signal for CARD in the nucleus. In contrast, p20 and p10 
subunits distributed almost equally between the nucleus and the cytoplasm. We did not observe 
differences between a-PCasp1 (knockdown of endogenous procaspase-1 to ~20%) and native THP-1 
cells indicating that antibody staining is very sensitive and detects small amounts of endogenous 
protein.  
Since antibody staining against the procaspase-1 subunits did not allow to distinguish between the 
endogenous and transduced fluorescent reporter fusion protein, we performed experiments in 
HEK293T cells, which lack endogenous procaspase-1 and pro-IL-1β. We transfected HEK293T cells 
with Ch, Ch-WT and Ch-L265S together with pro-IL-1β expression plasmids. Western blot analysis 
showed comparable protein expression, and CBA assays the expected IL-1β secretion in Ch-WT but 
not in Ch-L265S cells (data not shown). Using confocal laser scanning microscopy, we detected 
primarily cytoplasmic localization of the p.L265S variant, which was also shown by antibody staining 
of the caspase-1 subunits CARD, p20 and p10 (Suppl. Fig. 2B). 
Taken together, these results demonstrate that the fluorescent reporter attached to CARD does not 
influence subcellular distribution of procaspase-1 variants. Macrophages with variant procaspase-1 
p.L265S, however, exhibit disturbed nuclear localization of caspase-1 when compared to cells 
expressing wild-type caspase-1.  
 
Procaspase-1 variants do not influence phagocytic capacity of macrophages 
One major functions of monocytes and macrophages is the phagocytosis of pathogens. To address the 
question of whether procaspase-1 variants influence phagocytosis, we used the real-time quantitative 
live cell imaging IncuCyte platform (Essen BioScience) and analyzed the different cell lines for the 
capacity to phagocytose pHrodo Green E. coli BioParticles. Of note, phagocytosis between the cell 
lines varied insignificantly (Fig. 4).   
 
Procaspase-1 variants influence Gasdermin D processing and pyroptosis 
Knowing that procaspase-1 variants influence speck formation and IL-1β maturation and therefore the 
canonical inflammasome pathway, we investigated their influence on gasdermin-mediated 
programmed cell death, pyoptosis. Gasdermin D (GSDMD) is a substrate of caspase-1 and caspase-
11/4/5. It induces pore formation in the plasma membrane of monocytes/macrophages through its N-
terminal fragment, which oligomerizes and inserts in the plasma membrane giving rise to rapid cell 
lysis. The C-terminal part of GSDMD has inhibitory function and protects from pyroptosis [4, 30]. 
THP-1/a-PCasp1 cells either bearing WT procaspase-1 or variants were differentiated to macrophages 
using PMA, followed by priming with LPS and stimulation with nigericin to induce inflammasome 
assembly. Activation of WT procaspase-1 through the canonical inflammasome pathway led to 
GSDMD cleavage and the release of its N-terminal fragment, whereas enzymatically attenuated 
procaspase-1 variants showed abrogated (p.C285A) or decreased (p.L265S, p.R240Q) GSDMD 
cleavage (Fig. 5A). 
Furthermore, after priming with LPS, the addition of nigericin resulted in a significant increase of 
lactate dehydrogenase (LDH) release into supernatants of WT transduced cells, which was used as a 
measure of cell death (Fig. 5B). Procaspase-1 variants also showed an increased LDH release after 
nigericin stimulation, which, however, was lower when compared to WT cells.  
 
Procaspase-1 variants influence the deformability of macrophages after inflammasome stimulation 
Since migration of macrophages into tissues requires their activation and cell deformation, we tested 
whether procaspase-1 variants influence morphological properties of cells. THP-1/a-PCasp1 cells 
bearing WT or variant procaspase-1 were differentiated to macrophages using PMA, primed with LPS 
and stimulated with nigericin. Using the recently developed technique of real time deformability 
cytometry (RT-DC), macrophages were deformed in a microfluidic channel constriction of 30 µm, and 
mechanical and morphological cell parameters were measured in real-time [27, 31]. The inertia ratio, a 
parameter that quantifies deformation, and cell volumes were determined at 0 min and 20 min of 
treatment. The measured cell volume was not significantly different between WT and procaspase-1 
variant cell lines (GFP-WT, GFP-240, GFP-265, GFP-285) (Fig. 6A). The inertia ratio was 
significantly different at 0 min comparing GFP-WT versus GFP-L265S (p=0.04764) cells. 20 min 
after nigericin stimulation the inertia ratio, as a measure of deformation, showed significant 
differences between GFP-WT and GFP-L265S (p=0.04827) and also between GFP-WT and GFP-
C285A (p=0.01188) indicating a higher deformation of the procaspase-1 variants compared to WT 
(Fig. 6A-C). 
 
Discussion 
We recently showed that CASP1 variants [1, 32] that cause an autoinflammatory disease (CASP1-
AID) exhibit increased interaction with RIP2, thereby leading to enhanced activation of the pro-
inflammatory transcription factor NF-κB. This, in turn may contribute to uncontrolled engagement of 
inflammatory signaling pathways [3]. Since CASP1 mutations can also occur in asymptomatic family 
members and, at low frequencies, in the healthy normal population, many questions remain. We 
hypothesized that usually heterozygous CASP1 variants represent a disease-modifying factor in the 
context of other mechanisms that contribute to the expression of CASP1-AID. In this study, we 
focused on the effects of two disease-associated CASP1 variants (p.L265S, p.R240Q) and a described 
missense mutation in the active center of procaspase-1 (p.C285A) on inflammasome/pyroptosome 
formation, cell proliferation, phagocytic function and mechanical properties of macrophages.  
 
In the past, ASC speck formation was considered essential for IL-1β activation and release but not for 
pyroptosis [12]. Recently, however, we linked loss of (pro)caspase-1 activity to increased 
pyroptosome/speck formation in murine cells [29]. Reduced or absent enzyme activity stabilized the 
pyroptosome in murine macrophages and resulted in increased speck sizes, intensity and prolonged 
speck persistence, thus promoting interactions between ASC and procaspase-1 molecules in the 
pyroptosome. This was independent of the vital state of cells and could occur in the extracellular space 
after cell lysis. Furthermore, we suggested that pro-inflammatory signal transmission through 
spreading of specks during cell division may be an additional mechanism amplifying inflammation 
[29]. 
 
In the here described system of THP-1/a-PCasp1 cells, reconstitution with either WT or variant 
procaspase-1, priming with LPS and stimulation of NLRP3 inflammasome assembly with nigericin or 
ATP resulted in IL-1β release that was proportional to the residual enzymatic activity of procaspase-1 
variants. The formation of perinuclear specks/pyroptosomes was differentially influenced by 
individual procaspase-1 variants regarding the number, size and fluorescence intensity of specks and 
did not correlate with the residual enzymatic activity. Variants p.C285A (an artificial active center 
mutation) and p.R240Q (occurring as hetero- and homozygous mutation in patients) showed increased 
pyroptosome sizes and fluorescence intensity, which was comparable to previous findings in the 
murine p.C284A variant [29]. In contrast, the p.L265S procaspase-1 variant (heterozygous mutation in 
patients) associated with significantly reduced pyroptosome formation when compared to WT 
caspase-1, with smaller procaspase-1 specks and reduced fluorescence, while the size of the ASC 
specks did not differ. Assuming that the p.L265S variant is not subject to auto-processing [1], we 
detected all procaspase-1 subunits inside the specks by antibody staining for CARD, p20 and p10. 
Confirming our previous data from the murine system [29], we detected all three procaspase-1 
subunits inside the WT specks, co-localizing with ASC. Reduced speck formation in cells carrying the 
p.L265S variant may be explained by protein misfolding [1]. This, in combination with the absence of 
enzymatic activity in this variant (lack of auto-processing), may also contribute to disturbed 
subcellular localization (“nuclear exclusion”). Observed differences in speck formation, which do not 
associate with residual enzyme activity of tested procaspase-1 variants, suggest that further 
mechanisms exist that contribute to the pro-inflammatory phenotype in CASP1-AID patients.  
 
One of the major biological functions of monocytes and macrophages is their capacity as phagocytes. 
Thus, we analyzed the phagocytic ability of mutant p.R240Q, p.L265S and p.C285A CASP1 cell lines 
in response to PAMPs. The capacity to phagocytose pHrodo® Green E. coli BioParticles was not 
different between WT and the analyzed procaspase-1 variants.  
Since cytomechanical properties of cells correlate very closely with physiological and pathological 
changes in cell function, the measurement of cell mechanics as a biophysical characterization method 
of cytoskeletal changes has been established in recent years [33]. The relatively new method of real-
time deformability cytometry (RT-DC) allows the characterization of cell alterations associated with 
remodeling processes. It has been shown that efficient reorganization of the actin cytoskeleton is 
required for rapid ASC speck formation [34, 35]. Therefore, impaired speck formation by CASP1 
variants should lead to changes in cytoskeleton compliance. Using RT-DC we analyzed the influence 
of procaspase-1 variants on cell mechanics and found that CASP1 variants associate with higher cell 
deformability. As macrophage migration into tissues requires activation and mechanical deformation, 
one could speculate that a higher deformation of cells bearing procaspase-1 variants could facilitate 
the migration of macrophages. In contrast to our results, Ekpenyong and colleagues [33] reported 
increased cell rigidity of murine macrophages (BMDM) associated with S. typhimurium infection and 
therefore inflammation. The diverse results could be due to the use of different cell lines (human 
monocytic cells, THP-1 versus BMDM), stimulations (LPS and nigericin versus S. typhimurium 
infection) and techniques (RT-DC versus digital holographic microscopy, DHM). Further projects 
following this hypothesis are warranted and will analyze the exact influences of procaspase-1 variants 
on cell deformability and migration. 
 
Conclusions 
Procaspase-1 variants contribute to the inflammatory phenotype in patients with CASP1-AID despite 
decreased IL-1β release. In addition to previously reported increased interactions between procaspase-
1 variants and RIP2 [3], stabilization of ASC-pyroptosomes, and pyroptosome spreading during cell 
division [29], enzymatically attenuated human procaspase-1 variants do not prevent macrophages from 
pyroptosome formation, but influence the number, size and intensity of pyroptosomes independent of 
the residual enzymatic activity of caspase-1. Furthermore, human procaspase-1 variants do not 
influence cell proliferation and phagocytic capacity, however, lead to increased macrophage 
deformability, which could facilitate cell migration into inflamed tissue. Data from this study provide 
new insights into the involvement of caspase-1 in monocyte/macrophage biology and effects of 
reduced enzyme activity. Further investigations are needed to elucidate the exact molecular effects of 
CASP1 variants and modifying genetic and/or environmental factors causing CASP1-AID in some but 
not other individuals affected. 
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Figures 
Figure 1. Generation and characterization of human monocytic cell lines with procaspase-1 
knock-down and expression of fluorophore-tagged procaspase-1 variants. Fusion proteins of the  
green fluorophore (EGFP) tagged to either WT procaspase-1 (WT) or enzymatic inactive (p.C285A) 
or attenuated (p.L265S, p.R240Q) procaspase-1 variants were expressed in THP-1 cells with knock-
down of the endogenous procaspase-1 (a-PCasp1). EGFP alone served as control. Caspase-1 activation 
was induced by priming with 1 µg/ml LPS for 3 h, followed by 10 µM nigericin or 2 mM ATP for 1 h. 
A, THP-1 cells were lentivirally transduced with shRNA against the 3’-UTR region of the procaspase-
1 mRNA. The Western blot analysis shows a highly efficient knock-down of procaspase-1 expression 
(a-PCasp1) with a reduction of protein levels down to ~20%. Protein level of procaspase-1 fusion 
protein (PCasp1, 74 kDa), partially degraded caspase-1 (60 kDa) and endogenous or untagged 
procaspase-1 (~50 kDa) are shown by Western blotting with a caspase-1 CARD-detecting antibody 
(anti-Caspase-1 (scA-19)) and densitometric analysis (quantification of caspase-1 expression 
compared to β-Actin, which served as a loading control). Slightly different protein expression of 
variant procaspase-1 fusion-reporter proteins compared to WT remained despite repeated re-
generation of cell lines with different MOIs. B, Schematic drawing of procaspase-1 WT and variants is 
shown. The fluorescent protein (EGFP) was fused to the N-terminal CARD of procaspase-1. The 
analyzed mutations localize to the p20 subunit of procaspase-1. C, Caspase-1 expression of a-PCasp1 
cell lines reconstituted with WT or variant procaspase-1 measured by qRT-PCR. The relative mRNA 
expression was calculated as fold-increase compared to three reference genes (GAPDH/ALAS1/B2M).  
D+E, IL-1β release into supernatants was measured by cytometric bead array (D) and Western blot 
analysis (E). Cells expressing WT procaspase-1 (GFP-WT) secreted significantly more mature IL-1β 
compared to the inactive procaspase-1 variant p.C285A and GFP control when treated with both LPS 
and nigericin. IL-1β is displayed as fold increase compared to unstimulated GFP-WT cells. A,E, Data 
are representative of three independent experiments. C,D, Experiments are displayed as the mean ± 
SD. ns, not stimulated; WT, wildtype; scr, scramble shRNA; empty, reconstitution performed with 
empty vector; Sup, supernatant; ** p<0.01 
 
Figure 2. Enzymatically attenuated procaspase-1 variants do not prevent macrophages from 
pyroptosome formation but influences its number, size and intensity. Fusion proteins of EGFP 
tagged to either WT procaspase-1 (WT) or enzymatic inactive or attenuated (p.C285A, p.L265S, 
p.R240Q) procaspase-1 variants were expressed in THP-1 cells with knock-down of the endogenous 
procaspase-1 (a-PCasp1). EGFP alone served as control. Cells were differentiated with 2.5 ng/ml 
phorbol 12-myristate 13-acetate (PMA) to macrophages overnight. Caspase-1 activation was induced 
by priming with 1 µg/ml LPS for 3 h, followed by 10 µM nigericin and analysed by life-cell imaging. 
A, Representative fluorescence microscopy images of GFP-procaspase-1 specks at time point 310 min 
after the addition of nigericin are shown. Arrowheads indicate cells that formed specks. B, Life-time 
 
 
images of the fluorescence channel were aquired every 10 min over a time period of 400 min. At each 
time point, specks emerging for the first time were counted and added to the number of specks in 
previous slides. Specks were counted and related to the total amount of nuclei (Hoechst stains) within 
the same field. Between 700-1000 cells per cell line were analysed for speck formation. Results of two 
independent experiments are shown, which are representative for a total of 4 independent experiments. 
C, GFP-procaspase-1 specks, that were observed by fluorescence microscopy after 60, 120, 180, 240, 
300 and 360 min (B) were counted and related to the total amount of nuclei (Hoechst stains). 
Cumulative numbers of specks out of 4 independent experiments are shown. Statistical significance 
was determined using two-way Anova and multiple comparison test adjusted by Bonferroni. D, Speck 
size/diameter in cells expressing GFP-WT or GFP-tagged procaspase-1 variants was measured from 
fluorescence microscopy images (n=70 specks/cell line out of 4 independent experiments; one-way 
Anova with Sidiak’s multiple comparison test). E, Speck size in cells expressing Ch-WT or Ch-tagged 
procaspase-1 variant p.L265S was measured from confocal images (n=20 specks/cell line out of 5 
independent experiments; unpaired t-test, mean ± SD). F, As demonstrated in A, specks of the 
procaspase-1 variant cell lines show differences in their intensity. Graphs indicate mean values of 
maximum fluorescence intensities of GFP-WT or GFP-tagged procaspase-1 variant specks. First speck 
formation was set as the starting point (0 min) and assessed for each pyroptosome individually. 
Intensity levels 10 min before speck formation (-10 min) represent the background signal from the 
cytosol. Speck intensities after 100 and 200 min were chosen for statistical analysis in G (n=22/each 
time point).  
 
Figure 3: Variant procaspase-1 p.L265S formed smaller pyroptosomes compared to wildtype, 
and all procaspase-1 subunits are part of the pyroptosome. A, Representative fluorescence 
microscopy images of THP-1 cells with knock-down of the endogenous procaspase-1 (a-PCasp1) 
reconstituted with Cherry (Ch)-WT or Ch-L265S (red channel). Cells were differentiated with 2.5 
ng/ml phorbol 12-myristate 13-acetate (PMA) to macrophages overnight. Caspase-1 activation was 
induced by priming with 1 µg/ml LPS for 3 h, followed by 20 µM nigericin for 1 h. Then, cells were 
washed and stained with an antibody targeting ASC or the CARD, p20 or p10 subunit of caspase-1, 
followed by staining with an Alexa488 secondary antibody (green channel). The overlay of the red and 
green channel is shown as Merge. Nuclei were stained with Hoechst (blue channel). Ch-WT and Ch-
L265S co-localized with CARD, p10 and p20 in all pyroptosomes (Merge), whereas Ch control cells 
did not show pyroptosome formation in the red channel, however some pyroptosomes in the green 
channel, corresponding to the residual endogenous procaspase-1 after shRNA knockdown or to 
endogenous ASC. B, Quantification of speck positive cells compared to the total cell number of the 
image (n=700 cells/cell line out of 4 independent experiments; mean ± SD). Interestingly, in contrast 
to diminished numbers of Ch-L265S specks compared to Ch-WT, all cell lines (Ch-WT, Ch-L265S, 
Ch) generated the same amount of the ASC-specks. C+D, Macrophages with variant procaspase-1 
p.L265S showed disturbed nuclear localization compared to wildtype. Representative confocal 
microscopy images of THP-1 cells with knock-down of the endogenous procaspase-1 (a-PCasp1) 
reconstituted with Ch, Ch-WT or Ch-L265S (red channel). Cells were differentiated with 2.5 ng/ml 
phorbol 12-myristate 13-acetate (PMA) to macrophages overnight. Cells were stained with antibodies 
targeting the CARD, p20 or p10 subunit of caspase-1, followed by staining with an Alexa488 secondary 
antibody (green channel). The overlay of the red and green channel is shown as Merge. Nuclei were 
stained with Hoechst (blue channel). The enzymatically attenuated procaspase-1 variant p.L265S (Ch-
L265S) almost exclusively localized to the cytoplasm when fused to mCherry at their N-terminus. 
 
Figure 4: Procaspase-1 variants do not influence pHrodo Green E. coli Bioparticles 
phagocytosis of THP1 macrophages. A+B, THP-1 cells with knock-down of the endogenous 
procaspase-1 (a-PCasp1) reconstituted with WT and procaspase-1 variants (A, mCherry fusion 
proteins or B, “untagged”) were differentiated with 2.5 ng/ml phorbol 12-myristate 13-acetate (PMA) 
to macrophages overnight. Using the real-time quantitative live cell imaging IncuCyte platform 
(Essen BioScience) cell lines were analyzed side-by-side under the same conditions for their capacity 
to phagocytose pHrodo Green E. coli BioParticles, which only fluoresce when localized in the 
acidic environment of phagolysosomes. Aquired images were quantified for green object confluence 
(%) for each time point over 4 hours. Image analysis and fluorescence quantification were performed 
with the IncuCyte Basic Software. C, Representative images of fluorescence object quantification are 
shown at time point 0, 1 and 2 hours.   
 
Figure 5: Procaspase-1 variants influence Gasdermin D processing and therefore pyroptosis. A, 
THP-1/a-PCasp1 cells bearing procaspase-1 WT or variants were differentiated to macrophages with 
PMA, LPS-primed and stimulated with nigericin. The activation of WT procaspase-1 led to GSDMD 
cleavage and the release of its N-terminal fragment (p30), whereas enzymatically attenuated 
procaspase-1 variants show abrogated (p.C285A) or decreased (p.L265S, p.R240Q) GSDMD 
cleavage. A representative Western blot analysis is displayed. B, After LPS priming the addition of 
nigericin resulted in a significant increase of lactate dehydrogenase (LDH) release into supernatants of 
WT transduced cells, representing cell death (n=4). Procaspase-1 variants also showed an increased 
LDH release after nigericin stimulation, which was however less compared to WT.  
 
Figure 6: Morphological and mechanical properties of macrophages analyzed by real-time 
deformability cytometry (RT-DC). Representative scatter and contour plots (A) and statistical 
analysis (B) of inertia ratio, indicating increased inertia ration of GFP-285 and GFP-265 compared to 
GFP-WT. THP-1 cells were differentiated to macrophages with PMA (2.5 ng/ml, 16 h), LPS-primed 
(1 µg/ml, 3 h) and stimulated with nigericin. The inertia ratio as well as the volume (cell size) was 
determined for measurements taken at 0 min and 20 min of treatment. The cell volume was not 
significantly different for any of the states (GFP-WT, GFP-240, GFP-265, GFP-285) at any time point. 
The inertia ratio (I) is a parameter that quantifies deformation (I=1 means circle, higher I means more 
deformed). Linear mixed models analysis was performed to obtain statistical significance. Analyses 
have been performed using ShapeOut 0.8.8, *, p<0.05. 
 
Supplementary Figure 1. Generation and characterization of human monocytic cell lines with 
procaspase-1 knock-down and expression of mCherry-tagged and “untagged” procaspase-1 
variants. A, Representative Western blot analysis of THP-1 cells with knock-down of the endogenous 
procaspase-1 (a-PCasp1) and reconstitution with either “untagged”, “Flag-tagged” or fusion proteins 
of the red fluorophore (mCherry) tagged to either WT procaspase-1 (WT) or procaspase-1 variants are 
shown. mCherry, Empty vector, scr and THP-1 nativ served as controls. B, Western blot analysis 
shows a highly efficient knock-down of procaspase-1 expression (a-PCasp1) with a reduction of 
protein levels down to ~20%. Protein level of procaspase-1 fusion protein (PCasp1, 74 kDa), partially 
degraded caspase-1 (60 kDa) and endogenous or untagged procaspase-1 (~50 kDa) are shown by 
Western blotting with a caspase-1 CARD-detecting antibody (anti-Caspase-1 (scA-19)) and 
densitometric analysis (quantification of caspase-1 expression compared to β-Actin, which served as a 
loading control). C, Cell proliferation of all generated cell lines was examined side-by-side under the 
same conditions by using the real-time quantitative live cell imaging IncuCyte platform. The aquired 
phase contrast images were quantified for cell confluence over time. Cell proliferation was not 
affected by fluorescent tags and did not show differences for the analyzed procaspase-1 variants 
compared to WT cells (n=4). D, THP-1/a-PCasp1 reconstituted with Ch-WT or Ch-L265S were 
differentiated to macrophages with PMA, LPS-primed and stimulated with nigericin (as described 
above). Life-time imaging was performed and representative confocal microscopy images of both cell 
lines are shown (fluorescence channel). Nigericin stimulation resulted not only in speck formation but 
also in pyroptosis shown by an increase in cell volume, the occurrence of cell membrane vesicles, and 
a decrease in intracellular mCherry fluorescence intensity. Specks are marked with yellow arrowheads, 
scale = 20 μm. E, Quantitative fluorescence intensity analysis, showing the decrease of the mCherry 
fluorescence signal over time. After 80 sec, the unstimulated cell (ns) showed still more than 80% of 
the fluorescence intensity of its initial value (cell marked with white arrow). In contrast, nigericin 
stimulation led to a significant decrease of fluorescence intensity (down to 45% after 80 sec). The 
visible cell swelling after 120 sec results in a massive cytoplasmic outflow (and therefore loss of 
mCherry signal, white arrow), which is marked by the kink in the fluorescence intensity curve. After 
210 sec, almost no fluorescence signal of the cell was detectable. Quantification was done by using 
CellProfiler 2.0 software. AU, arbitrary units; scale = 20 µm. 
 
Supplementary Figure 2. A, Subcellular localization of procaspase-1 domains in native THP-1 
and THP-1/a-PC1 cells. Cells were differentiated for 24 hours with PMA to macrophages and stained 
with antibodies against the CARD (anti-caspase-1, sc A-19), the p20 (anti-caspase-1 p20, sc C-15) and 
the p10 subunit (anti-caspase-1 p10, sc C-20) of procaspase-1 followed by secondary staining with 
Alexa Fluor488 (green channel). Nuclei (Nc) were stained with NucBlue Fixed Ready Probes Reagent 
(blue channel). The merge displays the overlay of the blue and green channel. Representative confocal 
fluorescence images are shown. Scale = 20 μm; BF, bright field. B, Subcellular localization of 
procaspase-1 domains in transfected HEK293T cells. HEK293T cells were transfected with 
expression plasmids for Ch, Ch-WT and the CASP1 variant p.L265S (Ch-265). In addition, pro-
interleukin-1β (Pro-IL-1β) was co-transfected. Cells were fixed and stained with antibodies against the 
CARD domain, the p20 and the p10 subunit of procaspase-1 as mentioned above (green channel). 
mCherry fused WT and variant procaspase-1 are displayed in the red channel. The merge displays the 
overlay of the red and green channel. Representative confocal fluorescence images are shown. Scale = 
20 μm. 
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